Feature

Buyers' Clubs to Improve Access to Hepatitis C Treatment

As part of the World Health Organization's goal to eliminate viral hepatitis as a global health threat by 2030, the incidence of chronic new infections ...

Universal vs Risk-Based Screening in Pregnancy: An Expert Weighs In

There is a lack of consensus among experts and professional organizations whether HCV screening in pregnant women should be risk based or universal.

How Often Should We Test for Hepatitis C in People Who Inject Drugs?

A major challenge associated with hepatitis screening is the loss to follow-up that occurs in people who inject drugs.

Toward Integrated Care for Hepatitis C Infection and Addiction

There is an opportunity to improve HCV treatment rates for people who inject drugs by integrating DAA therapy into current models of community-based addiction.

Clinical Significance of the Isolated Anti-HBc Serologic Pattern

A serological pattern called isolated anti-HBc, characterized by the presence of hepatitis B core antibody (anti-HBc) and the absence of hepatitis B surface antigen and ...

Point-Counterpoint: Should We Implement Needle Exchange Programs for the Prevention of Hepatitis C Virus?

Of the approximately 12.7 to 16 million people who inject drugs (PWID) worldwide, an estimated 10 million individuals have hepatitis C virus (HCV), making it ...

Can Direct-Acting Antivirals Finally Achieve Hepatitis C Elimination?

Unrestricted use of DAAs may be an invaluable component of preventing HCV transmission by reducing the infectious pool of individuals.

Etiology of Acute Liver Failure Can Yield Surprising Findings

Before the advent of potent antiviral agents, liver transplantation was the only treatment option for patients with hepatitis and a poor prognosis; antiretrovirals can now ...

News Articles

Duration of Labor, Rupture of Membranes Do Not Effect HBV Vertical Transmission Risk

Duration of Labor, Rupture of Membranes Do Not Effect HBV Vertical Transmission Risk

After standard immunization, labor and rupture of membranes did not impact the transmission of hepatitits B to newborns.

Interferon Alfa May Decrease the Incidence of Chronic HCV Infection

Interferon Alfa May Decrease the Incidence of Chronic HCV Infection

Interferon alfa may decrease chronic HCV, but high-quality randomized trials are needed.

Success With DAA for Hepatitis C Prior to Stem Cell Transplant

Success With DAA for Hepatitis C Prior to Stem Cell Transplant

Children with HCV can achieve viral eradication throughout allogeneic HSCT if they receive full courses of DAA immediately before transplant.

Human Leukocyte Antigen System Likely Plays a Role in Course of HBV Infections

Human Leukocyte Antigen System Likely Plays a Role in Course of HBV Infections

Researchers demonstrated for the first time that the rs3077-T allele is associated with spontaneous hepatitis B virus seroclearance in a Caucasian population, a finding that has previously only been made in Asian populations.

Journal Articles

Sign Up for Free e-newsletters